<DOC>
	<DOCNO>NCT02017652</DOCNO>
	<brief_summary>CASMED , INC. wish validate next generation FORE-SIGHT-II ( FS-II ) NIRS tissue oximeter monitor neonatal brain somatic tissue oxygen saturation ( StO2 ) measurement . This monitor recently FDA clear use adult subject .</brief_summary>
	<brief_title>Validation Fore-Sight Cerebral &amp; Tissue Oximeter Saturation Measurements Neonates â‰¤ 5 kg</brief_title>
	<detailed_description>1 . Validate FS-II abdominal StO2 measurement intestine , liver , flank umbilical venous arterial blood oxygen saturation . 2 . Validate FS-II cerebral StO2 measurement predicate FDA clear FORE-SIGHT-I ( FS-I ) monitor . 3 . Collect data FS-II sensor forehead abdomen ( intestine ) 24 hour compare dynamic change vs pulse oximeter . For large neonate , add predicate FS-I sensor opposite side forehead dynamic comparison FS-II measurement . 4 . Obtain abdominal Near Infrared Spectroscopy ( NIRS ) data simultaneous accepted measure bowel motility ( a. frequency composition stool , b. Ultrasound assessment frequency magnitude bowel peristalsis , available ) .</detailed_description>
	<criteria>Neonatal subject ( 32 36 6/7 week ) , umbilical venous catheterization enrol Neonatal Intensive Care Unit . Enrollment study study period . Inability tolerate ultrasound NIRS sensor</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>bowel motility</keyword>
	<keyword>cerebral perfusion</keyword>
	<keyword>intestinal perfusion</keyword>
</DOC>